Results 201 to 210 of about 751,516 (267)

Dopamine D1Aa and D2a Receptor Expression in the Auditory System of a Vocal Fish. [PDF]

J Comp Neurol
Kobi K, Forlano PM.
europepmc   +1 more source

Mechanistic and therapeutic insights into class A GPCR dimers in neuropsychiatric disorders. [PDF]

NPJ Drug Discov
Wang Z, Wang L, Zhang S.
europepmc   +1 more source

Is continuous dopaminergic delivery still a major goal to be achieved in the treatment of Parkinson's disease? [PDF]

J Parkinsons Dis
Di Lazzaro G, Cimmino AT, Bentivoglio AR, Stocchi F, Calabresi P.   +4 more
europepmc   +1 more source

The Endogenous Opioid System in Compulsive Eating. [PDF]

Brain Sci
Janbandhu A, Leung C, Wu E, Tom A, Chang TD, Shah V, Kim L, Lauterborn ER, Lutfy K.   +8 more
europepmc   +1 more source

The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective. [PDF]

Basic Clin Pharmacol Toxicol
Wolfschlag M, Espa E, Hauer KO, Timpka J, Smith R, Odin P, Cenci MA, Håkansson A.   +7 more
europepmc   +1 more source

Exercise-Induced Metaplasticity: Breaking the Addiction Cycle in Methamphetamine Use Disorder. [PDF]

Sports Med Open
Wang D, Jin J, Hillman CH, Chang YK.
europepmc   +1 more source

Structure-Affinity Relationship Optimization of SYA16263 Yields New Ligands with Improved Receptor Affinity and Antipsychotic-Like Properties. [PDF]

ACS Omega
Gonela UM, Bricker BA, Voshavar C, Onyameh EK, Adzimah ME, Kuudaar EB, Morgan AA, Jones IL, Tellis EW, Ablordeppey SY.   +9 more
europepmc   +1 more source

Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities. [PDF]

Pharmaceuticals (Basel)
Li H, He X, Cao T, Huang J, Chen B, Xu L, Yang Y, Li G, Xiong L.   +8 more
europepmc   +1 more source